---
# An instance of the Blank widget.
# Documentation: https://sourcethemes.com/academic/docs/page-builder/
widget: blank

# Activate this widget? true/false
active: true

# This file represents a page section.
headless: true

# Order that this section appears on the page.
weight: 15

title: Information
subtitle:

design:
  columns: "1"
  background:
    image: headers/bubbles-wide.jpg
    image_darken: 0.6
    image_parallax: true
    image_position: center
    image_size: cover
    text_color_light: true
  spacing:
    padding: ["20px", "0", "20px", "0"]
---

{{% alert note %}}
**When to use?**

At admission in the emergency department, to stratify the in-hospital mortality risk of patients with COVID-19. 
{{% /alert %}}

{{% alert note %}}
**How was it developed and validated?**

Based in a cohort of 5,032 patients from 36 hospitals, from 17 cities in Brazil, as well as a cohort of 474 Spanish patients, following strict methodological criteria. [$^{1,2}$](https://abc2sph.com/#publications)
{{% /alert %}}

{{% alert note %}}
 **Why to use?**

   + It is easily calculated at bedside at admission.
   + It identifies four categories at increasing risk of death with a high level of accuracy, which outperformed other existing scores.
  + It may help healthcare practitioners to better identify patients with higher risk of mortality, to inform early interventions and the need of repetitive assessments to reduce the risk of death.
{{% /alert %}}

{{% alert note %}}
 **How it should be used?**

Only inhospital patients, through the use of variables easily accessible at admission.

{{% /alert %}}

{{% alert note %}}

**How it should not be used?**

  + It should not be considered a medical device.
  + It must not be interpreted as patients from low risk group may be discharged for home treatment.
  + It was validated in a cohort of Brazilian patients, and it should not be adopted for routine clinical use in other settings until it has been appropriately externally validated in those settings.
    
{{% /alert %}}



